Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria C Bolling

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
International Journal of Molecular Sciences|September 23, 2022
Towards a Better Understanding of Genotype-Phenotype Correlations and Therapeutic Targets for Cardiocutaneous Genes: The Importance of Functional Studies above PredictionMathilde C S C Vermeer, Daniela Andrei, Luisa Marsili, et al.
Clinical Drug Investigation|September 23, 2025
Mucous Membrane Pemphigoid Outcome Measurement in Clinical Research: A Scoping ReviewBillal Tedbirt, Eva W H Korte, Marjolein A J Hiel, et al.
Contact Dermatitis|April 26, 2020
Hyperkeratotic hand eczema: Eczema or not?Klaziena Politiek, Laura Loman, Hendri H Pas, et al.
The British Journal of Dermatology|April 25, 2023
Heterogeneity of reported outcomes in epidermolysis bullosa clinical research: a scoping review as a first step towards outcome harmonizationEva W H Korte, Tobias Welponer, Jan Kottner, et al.
Trials|October 10, 2025
Core outcome domain sets for clinical trials in epidermolysis bullosa - a COSEB protocol to achieve consensus on "what" to measureEva W H Korte, Peter C van den Akker, Dimitra Kiritsi, et al.
Experimental Dermatology|March 21, 2024
Epidermal growth factor receptor inhibition leads to cellular phenotype correction of DSP-mutated keratinocytesDaniela Andrei, Jeroen Bremer, Duco Kramer, et al.
Angewandte Chemie (International Ed. in English)|February 13, 2025
Synthetic High-Throughput Microarrays of Peptidoglycan Fragments as a Novel Sero-Diagnostic Tool for Patient Antibody ProfilingAlexandra Tsouka, Yanyan Fu, Manuel G Ricardo, et al.
Experimental Dermatology|March 24, 2022
Functional investigation of two simultaneous or separately segregating DSP variants within a single family supports the theory of a dose-dependent disease severityMathilde C S C Vermeer, Daniela Andrei, Duco Kramer, et al.
The British Journal of Dermatology|August 17, 2022
A translation re-initiation variant in KLHL24 also causes epidermolysis bullosa simplex and dilated cardiomyopathy via intermediate filament degradationMathilde C S C Vermeer, Mohammad Al-Shinnag, Herman H W Silljé, et al.
The Journal of Clinical Investigation|July 22, 2021
Gain-of-function mutation in ubiquitin-ligase KLHL24 causes desmin degradation and dilatation in hiPSC-derived engineered heart tissuesMathilde Csc Vermeer, Maria C Bolling, Jacqueline M Bliley, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
International Journal of Molecular Sciences|September 23, 2022
Towards a Better Understanding of Genotype-Phenotype Correlations and Therapeutic Targets for Cardiocutaneous Genes: The Importance of Functional Studies above PredictionMathilde C S C Vermeer, Daniela Andrei, Luisa Marsili, et al.
Clinical Drug Investigation|September 23, 2025
Mucous Membrane Pemphigoid Outcome Measurement in Clinical Research: A Scoping ReviewBillal Tedbirt, Eva W H Korte, Marjolein A J Hiel, et al.
Contact Dermatitis|April 26, 2020
Hyperkeratotic hand eczema: Eczema or not?Klaziena Politiek, Laura Loman, Hendri H Pas, et al.
The British Journal of Dermatology|April 25, 2023
Heterogeneity of reported outcomes in epidermolysis bullosa clinical research: a scoping review as a first step towards outcome harmonizationEva W H Korte, Tobias Welponer, Jan Kottner, et al.
Trials|October 10, 2025
Core outcome domain sets for clinical trials in epidermolysis bullosa - a COSEB protocol to achieve consensus on "what" to measureEva W H Korte, Peter C van den Akker, Dimitra Kiritsi, et al.
Experimental Dermatology|March 21, 2024
Epidermal growth factor receptor inhibition leads to cellular phenotype correction of DSP-mutated keratinocytesDaniela Andrei, Jeroen Bremer, Duco Kramer, et al.
Angewandte Chemie (International Ed. in English)|February 13, 2025
Synthetic High-Throughput Microarrays of Peptidoglycan Fragments as a Novel Sero-Diagnostic Tool for Patient Antibody ProfilingAlexandra Tsouka, Yanyan Fu, Manuel G Ricardo, et al.
Experimental Dermatology|March 24, 2022
Functional investigation of two simultaneous or separately segregating DSP variants within a single family supports the theory of a dose-dependent disease severityMathilde C S C Vermeer, Daniela Andrei, Duco Kramer, et al.
The British Journal of Dermatology|August 17, 2022
A translation re-initiation variant in KLHL24 also causes epidermolysis bullosa simplex and dilated cardiomyopathy via intermediate filament degradationMathilde C S C Vermeer, Mohammad Al-Shinnag, Herman H W Silljé, et al.
The Journal of Clinical Investigation|July 22, 2021
Gain-of-function mutation in ubiquitin-ligase KLHL24 causes desmin degradation and dilatation in hiPSC-derived engineered heart tissuesMathilde Csc Vermeer, Maria C Bolling, Jacqueline M Bliley, et al.
Pageof 4